Virulence Gene Expression Profiles (ALS3, HWP1, EFG1, SAP, EAP) in Biofilm-Forming Candida albicans Isolated from Vulvovaginal Candidiasis Patients
Abstract
Vulvovaginal candidiasis (VVC) is a prevalent fungal infection among women of reproductive age, with Candida albicans as the predominant etiological agent. The capacity of C. albicans to form biofilm constitutes a critical virulence determinant mediating infection persistence and antifungal resistance. This study aimed to analyze the expression of adhesin genes (ALS3, HWP1, EFG1) and extracellular enzyme genes (SAP, EAP) in C. albicans isolates from VVC patients and to correlate them with in vitro biofilm formation capacity. Sixteen C. albicans isolates were confirmed by conventional PCR from 33 Candida spp. isolates obtained from 72 VVC patients. Biofilm formation was quantified using the crystal violet method and MTS cell viability assay in 96-well microplates. Gene expression was analyzed by qRT-PCR using ACT1 as a housekeeping gene. All isolates demonstrated strong biofilm-forming capacity, with mean OD495 values ranging from 2.138 to 3.395. Clinical isolates exhibited significantly elevated expression of all target genes relative to the laboratory control strain, with the highest upregulation observed for EFG1 (2.57-fold) and EAP (1.95-fold). Positive correlations between virulence gene expression and biofilm capacity were confirmed. These findings indicate that the biofilm-forming potential of VVC-derived C. albicans is mechanistically linked to coordinated upregulation of adhesin and extracellular enzyme genes, providing molecular targets for novel antifungal strategies.
Keywords
Full Text:
PDFReferences
Alvarez, L., Kumaran, K. S., Nitha, B., & Sivasubramani, K. (2024). Evaluation of biofilm formation and antimicrobial susceptibility (drug resistance) of Candida albicans isolates. Brazilian Journal of Microbiology 2024 56:1, 56(1), 353–364. https://doi.org/10.1007/S42770-024-01558-W
Bras, G., Satala, D., Juszczak, M., Kulig, K., Wronowska, E., Bednarek, A., Zawrotniak, M., Rapala-Kozik, M., & Karkowska-Kuleta, J. (2024). Secreted Aspartic Proteinases: Key Factors in Candida Infections and Host-Pathogen Interactions. International Journal of Molecular Sciences 2024, Vol. 25, 25(9). https://doi.org/10.3390/IJMS25094775
Cavalheiro, M., & Teixeira, M. C. (2018). Candida Biofilms: Threats, challenges, and promising strategies. Frontiers in Medicine, 5(FEB), 342803. https://doi.org/10.3389/FMED.2018.00028/FULL
Chow, E. W. L., Pang, L. M., & Wang, Y. (2021). From Jekyll to Hyde: The Yeast–Hyphal Transition of Candida albicans. Pathogens 2021, Vol. 10, 10(7). https://doi.org/10.3390/PATHOGENS10070859
Ciurea, C. N., Kosovski, I. B., Mare, A. D., Toma, F., Pintea-Simon, I. A., & Man, A. (2020). Candida and Candidiasis—Opportunism Versus Pathogenicity: A Review of the Virulence Traits. Microorganisms 2020, Vol. 8, 8(6), 1–17. https://doi.org/10.3390/MICROORGANISMS8060857
Denning, D. W., Kneale, M., Sobel, J. D., & Rautemaa-Richardson, R. (2018). Global burden of recurrent vulvovaginal candidiasis: a systematic review. The Lancet Infectious Diseases, 18(11), e339–e347. https://doi.org/10.1016/S1473-3099(18)30103-8
Desai, J. V., Bruno, V. M., Ganguly, S., Stamper, R. J., Mitchell, K. F., Solis, N., Hill, E. M., Xu, W., Filler, S. G., Andes, D. R., Fanning, S., Lanni, F., & Mitchell, A. P. (2013). Regulatory role of glycerol in Candida albicans biofilm formation. MBio, 4(2). https://doi.org/10.1128/MBIO.00637-12;REQUESTEDJOURNAL:JOURNAL:MBIO;PAGE:STRING:ARTICLE/CHAPTER
Frías-De-león, M. G., Hernández-Castro, R., Conde-Cuevas, E., García-Coronel, I. H., Vázquez-Aceituno, V. A., Soriano-Ursúa, M. A., Farfán-García, E. D., Ocharán-Hernández, E., Rodríguez-Cerdeira, C., Arenas, R., Robledo-Cayetano, M., Ramírez-Lozada, T., Meza-Meneses, P., Pinto-Almazán, R., & Martínez-Herrera, E. (2021). Candida glabrata Antifungal Resistance and Virulence Factors, a Perfect Pathogenic Combination. Pharmaceutics 2021, Vol. 13, 13(10). https://doi.org/10.3390/PHARMACEUTICS13101529
Gaziano, R., Sabbatini, S., & Monari, C. (2023). The Interplay between Candida albicans, Vaginal Mucosa, Host Immunity and Resident Microbiota in Health and Disease: An Overview and Future Perspectives. Microorganisms 2023, Vol. 11, 11(5). https://doi.org/10.3390/MICROORGANISMS11051211
Georgieva, D., & Hitkova, H. Y. (2024). Species distribution and antifungal susceptibility of vaginal candida isolates. Problems of Infectious and Parasitic Diseases, 52(1), 13–17. https://doi.org/10.58395/2ENJ2697
Gerges, M. A., Fahmy, Y. A., Hosny, T., Gandor, N. H., Mohammed, S. Y., Mohamed, T. M. A., Abdelmoteleb, N. E. M., & Esmaeel, N. E. (2023). Biofilm Formation and Aspartyl Proteinase Activity and Their Association with Azole Resistance Among Candida albicans Causing Vulvovaginal Candidiasis, Egypt. Infection and Drug Resistance, 16, 5283–5293. https://doi.org/10.2147/IDR.S420580
Gharaghani, M., Shabanzadeh, M., Jafarian, H., & Zarei Mahmoudabadi, A. (2022). ABC typing and extracellular enzyme production of Candida albicans isolated from Candida vulvovaginitis. Journal of Clinical Laboratory Analysis, 36(1), e24117. https://doi.org/10.1002/JCLA.24117;JOURNAL:JOURNAL:10982825;WGROUP:STRING:PUBLICATION
Kaur, J., & Nobile, C. J. (2023). Antifungal drug-resistance mechanisms in Candida biofilms. Current Opinion in Microbiology, 71, 102237. https://doi.org/10.1016/J.MIB.2022.102237
Kumar, D., & Kumar, A. (2022). High throughput bioanalytical techniques for elucidation of Candida albicans biofilm architecture and metabolome. Rendiconti Lincei. Scienze Fisiche e Naturali 2022 34:1, 34(1), 117–129. https://doi.org/10.1007/S12210-022-01115-3
Masfufatun, masfufatun, Tri Ratnasari, D., Narottama, H., Purbowati, R., Kumala Indahsari, N., & Tjandra, L. (2024). Identification Of Candida Species in Vulvovaginalis Candidiasis Patients and Risk. The Indonesian Journal of Infectious Disease|, 10(2), 141–152.
Mayer, F. L., Wilson, D., & Hube, B. (2013). Candida albicans pathogenicity mechanisms. Virulence, 4(2), 119–128. https://doi.org/10.4161/VIRU.22913
Qian, G., Ding, L., Tan, C., Wang, L., & Long, C. (2025). Mucosal immune response modulated by secreted and membrane-bound hydrolases of Candida albicans in vulvovaginal candidiasis. Frontiers in Fungal Biology, 6, 1692795. https://doi.org/10.3389/FFUNB.2025.1692795/TEXT
Rosati, D., Bruno, M., Jaeger, M., Ten Oever, J., & Netea, M. G. (2020). Recurrent Vulvovaginal Candidiasis: An Immunological Perspective. Microorganisms 2020, Vol. 8, 8(2). https://doi.org/10.3390/MICROORGANISMS8020144
Schena, N. C., Baker, K. M., Stark, A. A., Thomas, D. P., & Cleary, I. A. (2023). Constitutive ALS3 expression in Candida albicans enhances adhesion and biofilm formation of efg1, but not cph1 mutant strains. PLOS ONE, 18(7), e0286547. https://doi.org/10.1371/JOURNAL.PONE.0286547
Sudbery, P. E. (2011). Growth of Candida albicans hyphae. Nature Reviews Microbiology 2011 9:10, 9(10), 737–748. https://doi.org/10.1038/nrmicro2636
Sun, Z., Ge, X., Qiu, B., Xiang, Z., Jiang, C., Wu, J., & Li, Y. (2023). Vulvovaginal candidiasis and vaginal microflora interaction: Microflora changes and probiotic therapy. Frontiers in Cellular and Infection Microbiology, 13, 1123026. https://doi.org/10.3389/FCIMB.2023.1123026/TEXT
Yan, C., Zhang, J., Yang, Y., Zeng, X., & Xiao, G. (2025). Virulence factors, biofilm formation and antifungal resistance in Candida albicans from recurrent vulvovaginal candidiasis patients: a comparative study. Scientific Reports 2025 15:1, 15(1), 37557-. https://doi.org/10.1038/s41598-025-21846-1
Yang, Y. H., Chen, J. Y., Chen, Y., Zhou, F. H., Lin, H. H., Lin, Y., & Xiao, G. W. (2022). Expression level of virulence factors of vaginal Candida albicans and its correlation with drug resistance. China Tropical Medicine, 22(5), 423–428. https://doi.org/10.13604/J.CNKI.46-1064/R.2022.05.06
Zhang, X., Essmann, M., Burt, E. T., & Larsen, B. (2000). Estrogen effects on Candida albicans: a potential virulence-regulating mechanism. The Journal of Infectious Diseases, 181(4), 1441–1446. https://doi.org/10.1086/315406
DOI: https://doi.org/10.14421/biomedich.2026.152.2163-2168
Refbacks
- There are currently no refbacks.
Copyright (c) 2026 Masfufatun Masfufatun, Harya Narottama, Diana Tri Ratnasari
Biology, Medicine, & Natural Product Chemistry |



